Submission Details
| 510(k) Number | K241317 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 10, 2024 |
| Decision Date | September 30, 2024 |
| Days to Decision | 143 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K241317 is an FDA 510(k) clearance for the Wondfo 2019-nCoV Antigen Test (Lateral Flow Method), a Over-the-counter Covid-19 Antigen Test (Class II — Special Controls, product code QYT), submitted by Guangzhou Wondfo Biotech Co., Ltd. (Guangzhou, CN). The FDA issued a Cleared decision on September 30, 2024, 143 days after receiving the submission on May 10, 2024. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3984.
| 510(k) Number | K241317 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 10, 2024 |
| Decision Date | September 30, 2024 |
| Days to Decision | 143 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | QYT — Over-the-counter Covid-19 Antigen Test |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3984 |
| Definition | For The Rapid, Qualitative Detection Of Sars-cov-2 Virus Nucleocapsid Protein Antigen In Individuals 2 Years And Older. |